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Abstract
Background: Ctip2 is crucial for epidermal homeostasis and protective barrier formation in developing mouse embryos.
Selective ablation of Ctip2 in epidermis leads to increased transepidermal water loss (TEWL), impaired epidermal
proliferation, terminal differentiation, as well as altered lipid composition during development. However, little is known
about the role of Ctip2 in skin homeostasis in adult mice.
Methodology/Principal Findings: To study the role of Ctip2 in adult skin homeostasis, we utilized Ctip2
ep2/2 mouse model
in which Ctip2 is selectively deleted in epidermal keratinocytes. Measurement of TEWL, followed by histological,
immunohistochemical, and RT-qPCR analyses revealed an important role of Ctip2 in barrier maintenance and in regulating
adult skin homeostasis. We demonstrated that keratinocytic ablation of Ctip2 leads to atopic dermatitis (AD)-like skin
inflammation, characterized by alopecia, pruritus and scaling, as well as extensive infiltration of immune cells including T
lymphocytes, mast cells, and eosinophils. We observed increased expression of T-helper 2 (Th2)-type cytokines and
chemokines in the mutant skin, as well as systemic immune responses that share similarity with human AD patients.
Furthermore, we discovered that thymic stromal lymphopoietin (TSLP) expression was significantly upregulated in the
mutant epidermis as early as postnatal day 1 and ChIP assay revealed that TSLP is likely a direct transcriptional target of
Ctip2 in epidermal keratinocytes.
Conclusions/Significance: Our data demonstrated a cell-autonomous role of Ctip2 in barrier maintenance and epidermal
homeostasis in adult mice skin. We discovered a crucial non-cell autonomous role of keratinocytic Ctip2 in suppressing skin
inflammatory responses by regulating the expression of Th2-type cytokines. It is likely that the epidermal hyperproliferation
in the Ctip2-lacking epidermis may be secondary to the compensatory response of the adult epidermis that is defective in
barrier functions. Our results establish an initiating role of epidermal TSLP in AD pathogenesis via a novel repressive
regulatory mechanism enforced by Ctip2.
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Introduction
Mammalian skin forms the first defense barrier in the body for
protecting against physical injuries, ultraviolet radiation, bacterial
infections as well as excessive loss of water [1]. The most abundant
cell type in epidermis is keratinocytes, which forms four layers:
basal, spinous, granular and stratum corneum [1,2]. Atopic
dermatitis (AD) is a chronic, inflammatory disease of the skin that
starts at early childhood. AD patients are genetically predisposes to
the disease, which has a prevalence of 10%–20% in children and
1%–3% in adults [3,4]. Clinical features of AD include skin
xerosis, pruritus and eczematoid skin lesions [4]. AD is charac-
terized by both skin barrier deficiencies and immunological
responses [5]. In AD, a defective skin barrier is thought to permit
the penetration of allergens and induces the interactions of the
allergens with immune cells, promoting the subsequent release of
pro-inflammatory cytokines and chemokines and elevation of IgE
level [6].
The molecular pathways involved in AD pathogenesis remain
unclear. There have been many reports on the connections
between atopic dermatitis and Th2 inflammatory pathways
[4,7,8]. Pro-Th2 cytokines, such as IL-4, IL-13, IL-5, and IL10,
are elevated in AD patients [7]. One possible candidate that has
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other allergic diseases is thymic stromal lymphopoietin (TSLP), a
member of the hematopoietic cytokine family. It is expressed at a
low level primarily by epithelial cells, including keratinocytes,
upregulated in acute and chronic AD lesions and responsible for
activating cutaneous DCs, endowing them with the capacity to
polarize CD4
+ T cells toward a Th2 cell allergic response [9–12].
TSLP signals through a heterodimeric receptor formed by TSLP
receptor (TSLPR) as well as IL-7 receptor alpha (IL7Ra) [9]. Mice
that are deficient of nuclear receptors (NRs) retinoid X receptor a
(RXRa), vitamin D receptor (VDR) or Notch1 in epidermal
keratinocytes, exhibit epidermal permeability barrier (EPB)
defects, express elevated levels of TSLP in skin, and subsequently
develop AD-like phenotypes [10,12–14].
Chicken ovalbumin upstream promoter transcription factor
(COUP-TF) interacting protein 2 (Ctip2), also known as Bcl11b, is
aC 2H2 zinc finger protein that is crucial in the development of
central nervous and immune system [15–18]. In T cells and
neuroblastoma cells, Ctip2 appears to function predominantly as a
transcription repressor. Ctip2 interacts indirectly with histone
deacetylases (HDACs) within the context of the Nucleosome
Remodeling and Deacetylation (NuRD) or SIRT1 complexes
[16,19,20]. Ctip2 also acts as a transcriptional activator in a
promoter-dependent manner in stimulated thymocytes [21,22].
Ctip2 is also expressed in human and mouse adult epidermis
[23,24]. Studies with mice harboring germline deletion and
epidermal specific ablation of Ctip2 revealed its critical role(s) in
epidermal proliferation and terminal differentiation, as well as
barrier formation during mouse embryonic development in both
cell autonomous and non-cell autonomous ways [25]. Ctip2 was
shown to be an important regulator of epidermal homeostasis and
barrier formation by interacting with the promoter regions of
many genes involved in epidermal development such as EGFR
and Notch1 and in skin lipid metabolism such as eLox3, Gba2 and
Lass2 ([26], Wang et al., 2012, in press). Since Ctip2-null mice die
at birth, the function(s) of keratinocytic Ctip2 in adult mice EPB
maintenance as well as in epidermal homeostasis is unknown.
Here we report a novel role of Ctip2 in maintenance of adult
epidermal homeostasis and in skin inflammation by selective Cre-
recombinase mediated ablation of Ctip2 gene in epidermal
keratinocytes of mice skin [27,28]. We show that ablation of
Ctip2 in mice epidermal keratinocytes during development results
in impaired EPB maintenance, increased epidermal hyperplasia
and a severe form of AD-like skin inflammation of adult skin that
becomes disseminated with progression of the disease, all of which
are very similar to AD in humans. Our present data indicates that
keratinocytic Ctip2 plays a crucial role in triggering skin
inflammatory responses by regulating the expression of genes
encoding Th2-type cytokines in adult mouse skin. These results
presented herein establish an initiating role of epidermal TSLP in
AD pathogenesis and demonstrate a key anti-inflammatory role of
Ctip2, which strongly represses TSLP expression in wild-type skin.
Results
Selective ablation of Ctip2 in epidermal keratinocytes
leads to altered epidermal proliferation, differentiation
and spontaneous dermatitis in adult skin
The function of Ctip2 in adult mice skin homeostasis was
characterized using Ctip2
ep2/2 mice that selectively lacked Ctip2
in epidermal keratinocytes by Cre-recombinase mediated deletion
of Ctip2 gene in keratinocytes using K14-Cre deleter mice [27,28].
At approximately 8–10 weeks after birth, 67% Ctip2
ep2/2 mice
(n=18) developed dry and scaly skin and 17% mutant mice also
developed spontaneous lesions on the dorsal skin at the same age,
which were absent in wildtype (WT) mice (Fig. 1A). The severity of
all of these abnormalities worsened with age (Figure 1A). By 4
months of age, almost all the mutants (89%, n=18) developed
spontaneous dermatitis that occurred predominantly on the dorsal
skin, in the neck region, and on the face (Figure 1A). Furthermore,
progressive alopecia was evident in most of the 4 month-old
Ctip2
ep2/2 mice (,85%) (Figure 1A). We hypothesized that the
skin lesions observed in the mutant mice could be due to impaired
function of the skin barrier. To test this hypothesis, trans-
epidermal water loss (TEWL) was measured in wildtype and
Ctip2
ep2/2 mice skin. Interestingly, the mutant mice showed
increased TEWL as early as 2 weeks of age, and the values were
,10-fold higher than wildtype mice at 4 months of age (Figure 1B;
note that 2 M and 4 M TEWL were measured on lesional skin
sites). At 4 M, TEWL of nonlesional mutant skin was a third of the
TEWL of lesional skin, but it was still 3.5-fold higher than WT
controls (Figure S1B). Histological analysis of hematoxylin- and
eosin- (H&E) stained skin sections revealed significant epidermal
hyperplasia in Ctip2
ep2/2 mice as early as 2 weeks of age
(Figures 1C and S1A).
In order to determine if increased epidermal hyperplasia could
be due to altered keratinocyte proliferation, immunohistochemical
(IHC) analyses for proliferation marker Ki67 and keratin 14 (K14)
were performed on control and mutant skin (Figures 1D and S1C–
D). The percentage of Ki67-positive cells was significantly higher
in Ctip2
ep2/2 epidermis compared to the wildtype littermates at
all time-points (Figure 1D, S1C). Similarly, the expression level of
K14 in the mutant epidermis was prominently increased in
Ctip2
ep2/2 mice at 2 and 4 months of age (Figure S1D).
Expression levels of the early differentiation marker K10 were not
significantly different between wildtype and Ctip2
ep2/2 mice
(Figure S1E). Expression of terminal differentiation marker
filaggrin was reduced in 1-week-old mutant epidermis (Figure
S1F); however, the decrease of its expression was transient, as
filaggrin expression became similar between WT and in Ctip2
ep2/
2 mice at later timepoints from 2 weeks to 4 months (Figure 1E,
S1F–G). The expression of loricrin was similar between wildtype
and Ctip2
ep2/2 mice at all timepoints (Figure 1F). These results
indicate that selective, somatic ablation of Ctip2 in epidermal
keratinocytes leads to increased epidermal proliferation and
unaltered terminal differentiation during adulthood. Altogether,
results suggest that adult Ctip2
ep2/2 mice exhibited impaired
barrier functions and developed spontaneous dermatitis that
further aggravated with age.
Increased infiltration of inflammatory cells in adult
Ctip2
ep2/2 mice skin
Dermal infiltrates were notable in Ctip2
ep2/2 mice starting
around 2 months of age, as revealed by histological analyses
(Figure 1C). Combined eosinophil and mast cell (C.E.M.) staining
revealed increased eosinophils in the dermis of Ctip2
ep2/2 mutant
skin around 1 month of age, while mast cells were most numerous
in the mutant dermis around 2 months of age (Figures 2A and
S2A). Besides the early induction of eosinophil and mast cells, IHC
staining for T lymphocytes revealed a two-fold increase in CD3
+ T
cells mainly at later timepoint in the skin of 4 month-old Ctip2
ep2/
2 mice compared to the wild-type skin (Figures 2B and C). A
similar late increase in the number of CD4
+ T cells was observed
in 4 month-old mutant skin compared to the wildtype skin
(Figure 2D–E). The number of F4/80+ macrophages in the dermis
was significantly higher in Ctip2
ep2/2 mice skin at 4 months of
age (Figure 3A–B). IHC staining using anti-Ly6g antibody showed
significantly increased number of neutrophils in the dermis of 4
Ctip2ep
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anti-CD11b antibodies revealed significantly increased number of
infiltrating monocytes, in the 4 months old mutant dermis
compared to the wild-type dermis (Figure 3E–F). In addition,
CD45
+ leukocyte infiltration was observed in one month-old
Ctip2
ep2/2 mice skin, but this resolved by 4 months of age (Figure
S2B–C). Expression of CD11c positive antigen for dendritic cells
was similar between wildtype and Ctip2
ep2/2 mice skin (Figure
S2D). Taken together, these results demonstrate an increased
inflammatory response in Ctip2
ep2/2 skin that progressively
increased with time.
Preferential induction of Th2-type cytokines and
chemokines in adult Ctip2
ep2/2 skin
Upregulated expression of cytokines and chemokines play a
crucial role in inflammatory skin diseases [7,29]. Differential
expression profiles of cytokines and/or chemokines orchestrate
and determine the type and outcome of inflammatory responses in
mouse and human skin. We next determined if expression of pro-
inflammatory cytokines/chemokines were dysregulated in mutant
skin. RT-qPCR analyses revealed a preferential induction of Th2-
type cytokines, including TSLP, CCL17, IL13, IL4, IL6, and IL10
in mutant skin (Figures 4A–E and S3A). In contrast, expression of
Th1-type (IL1a, IL2, IL12a/b; Figure S3B–E) was reduced and
that of Th17-type (IL17a, IL18 and IL23; Figure S3F–H)
cytokines was not induced in mutant skin.
Time course analyses also revealed several distinct induction
patterns of cytokines and chemokines in the mutant skin.
Chemokine CCL17 is one of known downstream genes whose
expression can be stimulated by TSLP [30]. CCL17 and IL13
transcripts were significantly induced in the mutant skin at around
1 week and 2 weeks after birth, respectively. Induction of these two
genes was transient, peaking at 1 month, followed by a decrease of
expression during later time points (2–4 months; Figure 4B and C).
In contrast to these early and transient inductions, we observed a
strong, late induction of cytokines IL4 and IL6 and chemokines
CCL3 and CXCL2 in the mutant skin (Figure 4D–E, S3L–M). We
Figure 1. Ctip2
ep2/2 mice develop a chronic skin lesions and
enhanced epidermal proliferation and differentiation. (A) Gross
morphology of 4 months old wildtype (WT) and Ctip2
ep2/2 mice. The
yellow arrowheads indicate lesion and alopecia of Ctip2
ep2/2 mice in
the back, face and neck, to be compared with the normal appearance in
a wildtype mouse. (B) Measurement of trans-epidermal water loss
(TEWL) from dorsal skin of wildtype and Ctip2
ep2/2 mice at different
time points. Statistical analyses were performed by student’s unpaired
t-test using GraphPad Prism software; ** P,0.01, *** P,0.001. (C)
Hemotoxylin & Eosin stained 5 mm thick paraffin sections from dorsal
skin of WT and Ctip2
ep2/2 mice at 1 week (1W), 2 weeks (2w), 1month
(1 m), 2 months (2 m) and 4 months (4 m). Immunohistochemical
staining of dorsal skin biopsies from WT and Ctip2
ep2/2 mice was
performed with antibodies directed against (D) Ki67, (E) Filaggrin and
(F) Loricrin (all in red). All sections were counterstained with DAPI
(blue). Scale bar: 100 mm. Epidermis (E) and dermis (D) are indicated.
doi:10.1371/journal.pone.0051262.g001
Figure 2. Characterization of inflammatory cell infiltrates in
dorsal skin of WT and in Ctip2
ep2/2 adult mice. (A) Combined
eosinophil and mast cell (C.E.M) staining for eosinophils (pink) and mast
cells (blue). Black arrows point to eosinophils. Scale bar: 50 mm. (B)
Immunohistochemical staining of dorsal skin biopsies from WT and
Ctip2
ep2/2 mice were performed with specific antibodies against CD3
(red). Yellow arrowhead indicates dermal infiltrates of CD3+ cells. Scale
bar: 100 mm. (C)P e r c e n tC D 3 + T cells at 2 m and 4 m. (D)
Immunostaining of CD4+ T cells (red) in WT and mutant mice. Scale
bar: 100 mm. (E) Percent CD4+ T cells at 2 m and 4 m. All sections were
counterstained with DAPI (blue). Statistical analyses were performed by
student’s unpaired t-test using GraphPad Prism software; ** P,0.005.
doi:10.1371/journal.pone.0051262.g002
Ctip2ep
-/- Mice Display Eczema-Like Skin Phenotype
PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e51262also observed a late onset of induction of Th1-type cytokines,
including TNFa and IFNc, at 4 months of age (Figure S3N–O).
TSLP, a master initiator of Th2 inflammatory responses, was
induced ,30-fold at postnatal day 1 (P1), and we observed a
,200-fold induction at P7 compared to control skin [31].
Expression of TSLP remained significantly high at all later time
points (,1000-fold induction between 1 month to 4 months after
birth; Figure 4A). Interestingly, the high level of TSLP expression
was observed predominantly in the mutant epidermis, whereas
TSLP transcripts were barely detectable in the dermal layer of the
mutant skin (Figure 4F). Immunohistochemistry analyses revealed
that TSLP protein was barely detectable and restricted to
differentiating layers of epidermis in WT skin, whereas TSLP
protein was strongly upregulated throughout the epidermis
including basal proliferative cells and differentiating keratinocytes
in the mutant skin (Figure S4A). These data provide strong
evidence that TSLP may be an initial triggering cytokine that is
induced in the absence of Ctip2 in the epidermis. Altogether, these
results suggest that deletion of Ctip2 in the epidermis leads to an
increased inflammatory response, which is characterized by a
Th2-type cytokine/chemokine profile.
TSLP is a direct target of Ctip2 in epidermal keratinocytes
Recent studies have revealed that ablation of RXRa and RXRb
in adult murine keratinocytes leads to an AD-like phenotype
triggered by induction of TSLP [13].Similarly, TSLP is also
elevated in Notch signaling-deficient keratinocytes (deficient in
either Notch1/2 or recombining binding protein suppressor of
hairless (RBP-j) [12,13,32]. Thus, it is possible that Ctip2 regulates
TSLP expression via the nuclear receptor or Notch signaling
pathways in epidermis. To test that, we determined the expression
of key players in both the Notch and RXR signaling pathways,
including Notch1, Notch2, RBP-j, RXRa and RXRb. Expression
of the corresponding transcripts was not affected by loss of Ctip2 in
the epidermis at both one and four months after birth (Figure
S5A–D, data not shown). Similarly, epidermal protein levels of
Notch1 and RXRa were comparable between wildtype and
mutants at all time-points, suggesting an alternative mechanism of
Ctip2-mediated regulation of TSLP expression in the adult murine
skin (Figure S5E–F).
In order to determine if Ctip2 directly regulates TSLP
expression in murine keratinocytes, we conducted chromatin
immunoprecipitation (ChIP) assays on neonatal mouse epidermal
extracts. Multiple primer sets were designed from the proximal
(2200 bp) and distal (21 kb) promoter regions relative to the
transcriptional start site of TSLP to determine the possible
interaction of Ctip2 with TSLP. We observed that Ctip2
interacted with the distal but not the proximal region of TSLP
promoter, suggesting Ctip2 may directly repress TSLP transcrip-
tion in mouse keratinocytes (Figure 4G). Hence, ablation of Ctip2
in epidermal keratinocytes could lead to upregulation of TSLP
expression due a derepression mechanism.
Systemic inflammatory responses in older Ctip2
ep2/2
mice
We hypothesized that chronic skin inflammation developed in
Ctip2
ep2/2 mice may trigger systemic immune responses in the
mutant skin. To test that we determined blood plasma concen-
trations of IgE as well as various Th2-type cytokines/chemokines
(IL-4, IL-13, CCL17 and TSLP) and Th1-type cytokine TNFa
from 1-month and 4-months-old mice by ELISA (Figure 5A–F).
Plasma level for all of the tested Th2 cytokines, were observed to
be higher in both 1-month and 4-month old mutant mice
(Figure 5A–E), including IL4 and the related IL-13 (Figure 5A, B),
CCL17 (Figure 5C) and TSLP (Figure 5D). In contrast, plasma
level of Th1 cytokine TNFa was higher only at 4-month but not in
1-month old mutant mice (Figure 5E). While circulating IgE levels
were elevated in both wild-type and mutant mice at four months of
age, IgE levels in mutant mice were 2.5 times greater than those in
wildtype mice (Fig. 5F).
Ctip2
ep2/2 mice exhibited inguinal lymphadenopathy and
smaller convoluted thymus at four months of age (Figure 5G, data
not shown). The mutant mice displayed progressive splenomegaly
starting from one month of age, with a 2-fold increase in spleen
weight at the age of four months (Figure 5G–H). Histological
studies of the spleens revealed an increased cell infiltration in the
4-month-old mutant spleen in comparison with wildtype (Figure
S6 A, D, G, J). 4 month-old Ctip2
ep2/2 mice exhibited increased
eosinophil infiltration in the spleen and lymph node compared
with wildtype (Figure S6, B, E, H, K). Very few mast cells were
observed in both wildtype and mutant mice spleens and the
number of mast cells was larger in the lymph node, indistinguish-
able between 4 month-old wildtype and mutant mice (Figure S6,
Figure 3. Increased inflammatory cell infiltrate in Ctip2
ep2/2
adult mice. (A) Immunohistochemical staining of dorsal skin biopsies
from WT and Ctip2
ep2/2 mice were performed with specific antibodies
against F4/80 (green) to detect macrophage/dendritic cells. (B) Percent
F4/80 positive cells at 2 m and 4 m. (C) Immunostaining of neutrophils
(green) using anti-Ly6g antibody in WT and mutant mice skin. (D)
Percent Ly6g positive cells at 2 m and 4 m. (E) Immunostaining of
monocytes/macrophages (green) with anti-CD11b antibody in WT and
mutant mice skin. (F) Percent CD11b positive cells at 2 m and 4 m. All
sections were counterstained with DAPI (blue). Scale bar (A, C, and E):
100 mm. Statistical analyses were performed by student’s unpaired t-
test using GraphPad Prism software; * P,0.05, ** P,0.005.
doi:10.1371/journal.pone.0051262.g003
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ep2/2 mice
display a systemic immune response that may be primarily driven
by TSLP expression from keratinocytes.
Discussion
Epidermal keratinocytes have long been suspected to play a
crucial role in initiating and directing the immune response in
inflammatory skin diseases, such as AD. In the present report we
have shown that skin of adult Ctip2
ep2/2 mice, with an
epidermal-specific deletion of the gene encoding Ctip2, display
histological and cellular features that are typical of human AD.
First, Ctip2
ep2/2 mice develop skin lesions, alopecia and pruritus,
which are major clinical features in patients afflicted with AD
[4,33,34]. Second, Ctip2
ep2/2 mice exhibit epidermal hyperplasia
that is characterized by increased epidermal proliferation, similar
to what has been observed in AD patients [2]. Third, the skin of
Ctip2
ep2/2 mice is characterized by a dramatic upregulation of
Th2-type cytokines and chemokines, including TSLP, CCL17,
IL13 and IL4, all of which were induced early in Ctip2
ep2/2
epidermis, and are crucially involved in the initiation of
pathogenesis in human AD [3,7,35]. Finally, Ctip2
ep2/2 adult
mice exhibit Th2-like systemic immune syndrome that is similar to
that found in most AD patients [36]. Based on the above
phenotypic spectrum of Ctip2
ep2/2 adult mice, it appears that this
line may serve as a useful model for the study of human AD.
During development, selective ablation of Ctip2 in the
epidermis reduced epidermal proliferation and impaired terminal
differentiation of keratinocytes [25]. Isolated Ctip2-null keratino-
cytes also exhibit severe proliferation and differentiation defects in
culture [26]. To our surprise, in the postnatal stages, a hyperplastic
epidermis and a significantly higher percentage of Ki67-positive
cells were observed in the Ctip2
ep2/2 skin as early as 1 week after
birth (Figure 1). Elevated proliferation could be secondary to
impaired epidermal barrier functions caused by Ctip2 ablation.
Previous studies have established that hyperproliferation and
acanthosis (thickened epidermis) are compensatory responses and
secondary to impaired epidermal barrier [37–40]. It is also
Figure 4. Th2-dependent cytokine and chemokine expression levels in WT and Ctip2
ep2/2 skin. (A–F) Quantitative RT-PCR (RT-qPCR)
analyses of cytokines and chemokines in the dorsal skin of 1day, 1 week, 2 weeks, 1month, 2 months and 4 months old WT and mutant mice using
specific primers as indicated in Table S1. Relative mRNA expression levels of (A) TSLP, (B) CCL17, (C) IL13, (D) IL4, and (E) IL6 in Ctip2
ep2/2 skin was
compared to wildtype (WT) skin (set as 1.0). (F) RT-qPCR analyses of TSLP mRNA levels in separated epidermis and dermis from tail skin. All values
represent relative transcript level after normalization with HPRT transcripts. (G) Chromatin immunoprecipitation (ChIP) assay was performed on
freshly isolated neonatal mouse skin keratinocytes using anti-Ctip2 antibody and results were analyzed by qPCR using primers indicated in Table S1.
Rat IgG was used as a control. Ctip2 was recruited to the distal promoter regions of TSLP. Statistical analyses were performed by student’s unpaired t-
test using GraphPad Prism software; * P,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0051262.g004
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ep2/2 mice skin could
be partially due to deficiency in tight junctions. That possibility
was ruled out since immuno-histochemical staining of dorsal skin
exhibited no significant difference in tight junction protein
expression including beta-catenin, E-cadherin, claudin-1 and
claudin-4 between wildtype and mutant mice (Figure S4B–E).
A number of candidate genes have been identified in association
with AD, however, many of these linkages have been called into
question due to insufficiently powered studies and/or heterogene-
ity of the disease [33,34]. In independent studies, several genes
such as Filaggrin (FLG), trans-acting T-cell-specific transcription
factor (GATA3) and IL4 has been reported to be involved in AD
pathogenesis [41]. FLG deficiency alone decreases stratum
corneum hydration and leads to increased TEWL, and has been
correlated with AD in the highest number of studies [41,42]. It is
worth mentioning that skin barrier deficiency has also been
reported in AD patients without FLG mutation(s) or loss of
expression [43] suggesting existence of different subtypes of AD in
humans. We have shown previously that Ctip2 deficiency is
associated with impaired terminal differentiation and decreased
FLG expression during development [25]. Indeed, we have
observed a ,50% reduction of FLG expression in the epidermis
of Ctip2
ep2/2 skin compared to that of wildtype littermates
around 1 week of age (Figure S1F). However, no significant
difference in level of FLG expression was observed between the
wildtype and mutant epidermis at later timpoints from 2 weeks to
4 months of age, possibly due to a compensatory upregulation of
other related factors such as Ctip1 (Figure 1E). The lack of loss-of-
FLG expression observed in Ctip2
ep2/2 mice at later stages
indicates possible involvement of other factors to modulate barrier
integrity.
It appears that during adulthood, the requirement of Ctip2 for
epidermal proliferation and differentiation is compensated by
upregulation of a Ctip2-independent growth pathway. The
increase of epidermal proliferation may also be secondary to the
inflammatory phenotype together with defects in barrier function.
The role of Th2 cytokines in AD skin lesion is to promote the
recruitment, proliferation and development of Th2-type immune
cells to lesional site, whereas their direct roles in keratinocyte
proliferation still remain largely unknown. Activation of TSLP
signaling in dendritic cells and T cells is known to activate multiple
growth pathways, including STATs, Src kinases, PI3K and
ERK1/2 [44–48]. It is possible that inflammatory cytokines, such
Figure 5. Systemic immunological abnormalities in Ctip2
ep2/2 adult mice. Serum concentration of (A) IL4, (B) IL13, (C) CCL17, (D) TSLP, (E)
TNFa and (F) IgE was measured by ELISA. (G) Gross morphological comparison of spleen, lymph node (LN) and liver in 4-months-old WT and
Ctip2
ep2/2 mice. (H) Spleen weight of WT and Ctip2
ep2/2 mice at different months of age is indicated. Statistical analyses were performed by
student’s unpaired t-test using GraphPad Prism software; * P,0.05, ** P,0.01, *** P,0.005.
doi:10.1371/journal.pone.0051262.g005
Ctip2ep
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Ctip2
ep2/2 adult epidermis.
TSLP, a keratinocyte-derived triad of cytokines, has been
studied intensively recently in the pathogenesis of allergic
inflammation and subsequent development of AD and other
immune disorder [31,49,50]. It is recognized as the master switch
for AD and other atopic diseases, such as asthma, as it plays a
critical role to induce the Th2-type allergic inflammation in AD
pathogenesis [31]. Keratinocyte-derived TSLP participates in the
inflammatory cascade by activation of other immune cells, such as
dendritic cells and mast cells, and subsequent stimulation of release
of Th2-related cytokines/chemokines from these immune cells,
eventually initiate inflammatory a Th2 lymphocyte response
[9,49,51]. In the present study, we have observed that TSLP
was the earliest known cytokine induced in Ctip2
ep2/2 mice and
this induction was maintained in the mutants at all postnatal stages
of development. The induction of TSLP was mainly restricted to
the epidermis, which correlates well with epithelial cells of the
keratinocyte lineage as major producers of TSLP in AD patients
(see Figures 4F and S4A) [49]. Hence, induction of TSLP in Ctip2
mutant keratinocytes could be a trigger factor that initiates and
directs the Th2-type inflammatory cascade observed in Ctip2
ep2/
2 skin.
Transgenic mice over-expressing TSLP in keratinocytes develop
AD-like symptoms, indicating that TSLP expression is sufficient to
initiate AD-like inflammatory responses [50]. Therefore, it
remains critical to address upstream triggers of TSLP expression
and how TSLP is regulated before and during AD pathogenesis.
Putative NF-kB response element has been detected in the mouse
and human TSLP gene promoter and NF-kB regulated mouse
and human TSLP gene expression in presence of inflammatory
cytokines in vitro [13,14,52–54]. Putative AP-1 transcription factor
binding motif was also detected on the promoter region of human
TSLP gene [13,14,52–54]. Similarly, nuclear receptor (NR) RXR
directly repressed TSLP transcription through the binding of
RXR-VDR and RXR-RARc heterodimer containing co-repres-
sor complexes to the mouse TSLP promoter [13,14,52–54].
Previous studies have also identified presence of putative VDREs
(DR3) and RAREs (DR2 and DR1) upstream of the human TSLP
promoter [14]. Since we have observed Ctip2 recruitment around
that region on the mTSLP promoter, it is possible that NRs and
Ctip2 could be a part of the same transcriptional complex to
regulate TSLP gene expression in mouse keratinocytes. However,
additional recruitment of Ctip2 along with NRs on the further
distal region of mouse TSLP gene promoter cannot be ruled out.
Here, we have identified a novel transcriptional regulatory
mechanism(s) of negative regulation of TSLP expression by Ctip2
in mouse epidermis. Ctip2 appears to interact directly with and
repress expression of the TSLP promoter.
We have demonstrated a predominant upregulation of Th2
cytokines in the Ctip2
ep2/2 skin at all timepoints, but a late surge
of Th1 cytokines, including IFNc and TNFa, was also observed in
the mutant skin at 4 months (Figure S3N-O). Indeed, it has been
demonstrated that Th2- and Th1 type cytokines both contribute to
different stages of the development of skin lesions in AD patients
[29]. Th2-cell subsets are specifically activated during the
initiation phase, followed by the Th1-cell subset to maintain the
persistence of the chronic inflammatory response. Our work
confirms that Th2- and Th1-type immune responses are not
mutually exclusive, especially at the chronic phage of the
inflammatory disease. The interaction between different Th-cell
subsets at the chronic stage may be a fruitful area for future
investigation of AD pathogenesis.
Systemic immune response related to elevated expression of IL-
4, IL13, CCL17 and IgE, observed in Ctip2
ep2/2 mice is
evidently Th2 cell-dependent and humoral in nature. IL-4, for
example, induces differentiation of CD4
+ T-cells into Th2 cells,
and also inhibits production of Th1 cells [55]. Th2 cells secrete IL-
13, which together with IL-4, initiates a B lymphocyte-directed,
humoral response [55]. IL-4 also upregulates MHC class II
expression and induces B-cell class switching to IgE [56].
Furthermore, TSLP stimulation of naı ¨ve CD4
+ T-cells induces a
specialized Th2 polarization, which results in production of
downstream Th2-associated pro-inflammatory cytokines, such as
IL-13, which carry out humoral immune processes [30]. Simul-
taneously, CCL17 is known to attract Th2 cells, thereby favoring
humoral responses [57]. In summary, inflammation due to
selective Ctip2 ablation in mice epidermis is not restricted to the
site of deletion; rather Ctip2
ep2/2 mice show a chronic secondary
Th2-dependent humoral systemic inflammatory response that
could possibly lead to inflammation of airway and pulmonary
epithelium and asthma.
Our group has previously shown that Ctip2 expression was
increased in samples from AD and ACD patients, and here we also
show an increase of Ctip2 expression in the epidermis of another
known mouse AD model (RXRa
ep2/2; Figure S7A–B) [24].
Based on our study here, we hypothesize that induction of Ctip2
during AD progression may have a protective role, which is to
suppress the inflammatory response by inhibiting TSLP expres-
sion. In contrast, the elevated proliferation in the Ctip2
ep2/2 mice
epidermis is likely due to compensatory responses and secondary
to impaired epidermal barrier functions. Additional studies to
determine TSLP level in AD and ACD patients with elevated
Ctip2 expression will be useful to validate our hypothesis.
In summary, our study reveals a novel role(s) of keratinocytic
Ctip2 in epidermal barrier maintenance and homeostasis, and
inflammation in adult mice. Ctip2 clearly modulates AD-like
responses within the skin, as well as systemic inflammatory
responses. TSLP was strongly induced in Ctip2
ep2/2 epidermis
and likely causes increased dendritic cells infiltration into lymph
nodes, in which these cells interact with CD4
+ T cells to produce
Th-2 inflammatory cytokines. Subsequently, other immune cells
such as macrophages, leukocytes, mast cells and eosinophils could
be attracted and recruited to the site of skin inflammation, which
become disseminated, leading to elevated circulating levels of
inflammatory mediators. This study identifies a new mediator,
Ctip2, which may be implicated in the etiology of AD. However,
several issues need to be resolved in the future. For example, it is
presently unclear if a defective skin barrier precedes inflammation
and enhanced cellular proliferation in the early stages of AD
development. Second, the contributory role of TSLP in AD and
the mechanistic basis of regulation of TSLP gene expression in
mouse and human keratinocytes have not been fully elucidated.
Finally, the role of Ctip1 in AD development in presence or
absence of Ctip2 could shed further lights in AD pathogenesis and
identify new avenues for therapeutic intervention. Our study
highlights a central role of epidermal keratinocytes in initiating
and shaping the immune response during the pathogenesis of AD-
like skin diseases in mice.
Materials and Methods
Mice
The function of Ctip2 in adult mice skin homeostasis was
characterized using Ctip2
ep2/2 mice that selectively lacked Ctip2
in epidermal keratinocytes after Cre-recombinase mediated
deletion of Ctip2 gene in keratinocytes using K14-Cre deleter
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L2/L2, wildtype) were
used as controls [25,28]. 8 to 10 mice from multiple litters were
used in each group at each time point. Mice were maintained in a
temperature/humidity-controlled facility with a 12-hour light/
dark cycle. Animal protocol was approved by Oregon State
University Institutional Animal Care and Use Committee
(IACUC), under permit number 4300.
Transepidermal water loss (TEWL) measurement
Transepidermal water loss was measured using the calibrated
Tewameter TM300 with Multi Probe Adapter (CK electronic
GmbH, Ko ¨ln, Germany) in accordance with manufacture
operating instructions. Data was expressed in g/m
2 h, and
represents the mean 6 S.E.M. for 8 independent animals (10
measurements each animal) of each genotype. Statistical analysis
was performed using Graphpad Prism software with student’s
unpaired t-test.
Histological analysis
Skin biopsies were fixed in 4% paraformaldehyde overnight and
embedded in paraffin blocks. 5 mm paraffin sections were
sectioned using a Leica RM2255 microtome (Bannockburn, IL).
Hematoxylin and eosin staining was performed according to
general protocols [58].
Combined eosinophil/mast cell stain (C.E.M) was performed
using a commercial kit according to the manufacturer’s protocol
(American MasterTech, Lodi, CA). Briefly, slides were deparaffi-
nized with xylene and hydrated through alcohols. After washed in
running tap water, slides were placed in astra blue staining solution
for 30 minutes and rinsed in tap water. Slides were put in vital new
red staining solution for another 30 minutes and rinsed with tap
water. After that, slides were placed in modified Mayer’s
hematoxylin for 15–30 seconds and rinsed again with tap water
for 2 minutes. Finally, dehydration of slides was performed with 3
changes of absolute alcohol and xylene before mounting. Mast
cells showed bright blue color while eosinophils were red. Nuclei
were stained blue.
Toluidine blue staining was performed as described [13].
Toluidine blue working solution was prepared by mixing 5 ml 1%
toluidine blue EtOH solution (Sigma-Aldrich, St. Louis, MO) with
45 ml 1% sodium chloride (pH 2.3). Slides were deparaffinized
and hydrated in distilled water. Sections were stained with
toluidine blue working solution (pH 2.0–2.5) for 2–3 minutes
before washed in 3 changes of distilled water. Slides were
dehydrated through alcohols and xylenes and mounted with
resinous mounting medium.
Immunohistochemistry
IHC staining of paraffin and frozen sections was described
previously [58,59]. In brief, paraffin sections were deparaffinized
and antigen retrieval was performed with pH 6.0 citrate buffer
and 95–100uC for 20 minutes and cooled down. For frozen
sections, slides were fixed with cold acetone for 20 minutes and
allowed for air dry. Slides were washed with 0.1% PBST and
blocked with 10% normal goat serum (Vector Laboratories,
Builingame, CA) for 30 minutes before incubated with primary
antibodies overnight at 4uC. Fluorescently labeled secondary
antibodies were applied to slides for an hour at room temperature.
Nuclei were visualized with DAPI. After the final washes, slides
were dehydrated and mounted. Images were captured at 620
magnification using a Carl Zeiss Axio Imager Z1 fluorescent
microscope and AxioCam camera. Data were analyzed and
quantified using Adobe Photoshop and ImageJ software. Multiple
IHC fields were randomly chosen and 10–15 such fields per slide
were counted independently in a double-blinded manner. All
experiments in each category were repeated in triplicates.
The concentrations of antibodies used were as follows: Ki67
(Abcam, Cambridge, MA, 1:500), K14 (Abcam, 1:1000), K10
(Abcam, 1:1000), Filaggrin (Abcam, 1:1000), Loricrin (Abcam,
1:500), F4/80 (Biolegend, San Diego, CA, 1:250), CD11b (Abcam,
1:100), CD45 (Abcam, 1:500), Ly6g (Abcam, 1:250), CD11c (BD
Pharmingen, San Jose, CA, 1:100), RXRa (Santa Cruz Biotech-
nology, Santa Cruz, CA, 1:1000), Notch1 (Cell Signaling
technology, Danvers, MA, 1:500), Ctip2 (Abcam, 1:300), Claudin4
(Abcam, 1:50), Claudin1 (Abcam, 1:100), E-cadherin (Cell
Signaling, Danvers, MA, 1:200), b-Catenin (Cell Signaling,
1:50), TSLP (Invitrogen, 1:100), Cy3 goat anti rabbit (Jackson
ImmunoResearch Laboratories Inc., West Grove, PA, 1:500), Cy3
goat anti rat (Jackson ImmunoResearch, 1:500), Cy2 goat anti rat
(Jackson ImmunoResearch, 1:500), Cy3 goat anti mouse (Jackson
ImmunoResearch, 1:1000).
RT-qPCR
RNA extraction and cDNA preparation were performed as
described [60]. Real-time PCR was performed on an ABI 7500
Real-Time PCR system using SYBR Green methodology using
specific sets of primers as indicated in Table S1 [60,61]. Relative
gene expression analysis of the RT-qPCR data was performed
using HPRT as an internal control. All assays were performed in
triplicates.
ELISA
ELISA kits for detecting mouse IL-4, IL-13, TNFa and TSLP
were obtained from eBioscience, Inc. (San Diego, CA, USA).
Mouse IgE ELISA kit was procured from Bethyl Laboratories, Inc.
(Montgomery, TX, USA), while CCL17 immunoassay kit was
purchased from R&D Systems, Inc. (Minneapolis, MN, USA).
1-month and 4-month-old mice (6 wildtypes and 6 Ctip2
ep2/2
from each age group) were selected for studying secondary
systemic response to Ctip2
ep2/2 genotype. Blood plasma was
isolated from the mice following the method of Argmann and
Auwerx [62]. ELISA was performed for estimation of the levels of
IL-4, IL-13, IgE, CCL17, TNFa and TSLP using kits following
the respective manufacturer’s instructions. All samples were
assayed in triplicates.
Chromatin immunoprecipitation (ChIP)
ChIP assay was performed according to Hyter et al., 2010 with
minor modifications [63]. Briefly, mouse epidermal keratinocytes
from 1-day postnatal wildtype mice skin were isolated and fixed in
1% formaldehyde. Cell lysate from 3610
6 keratinocytes (each
ChIP) were obtained after incubation with hypotonic buffer
(10 mM Tris/HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl2 and
0.5% NP40). Nuclei were suspended in ChIP sonication buffer
(50 mM Hepes, pH 7.9, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100, 0.1% SDS, 0.1% sodium deoxycholate) with 0.2%
SDS. Nuclei were sonicated and immunoprecipitated with 2 mg
anti-Ctip2 antibody (Abcam, Cambridge, MA) overnight at 4uC.
Rat IgG was used as a control. 25 ml pre-equilibrated protein G
beads (Invitrogen, Carlsbad, CA) were added to each ChIP and
incubated for four hours at 4uC. After washing twice with ChIP
sonication buffer, buffer A (50 mM Hepes, 500 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 0.1% SDS and 0.1% sodium
deoxycholate), buffer B (20 mM Tris/HCl, pH 8.0, 1 mM EDTA,
250 mM LiCl, 0.5% NP40 and 0.5% sodium deoxycholate) and
once with TE buffer, DNA was uncrosslinked at 65uC overnight
and purified by QIAquick PCR Purification Kit (Qiagen,
Germantown, MD). All the buffers used in the study were added
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using ABI-7500 Real-time PCR machine with specific primers
indicated in Table S1. Primers were designed from proximal
(2200 bp) and distal (21 kb) promoter regions of TSLP to study
the possible interaction between Ctip2 and TSLP, and primers
selected from 39-UTR region was used as a control.
Western blotting
Protein was extracted from mouse epidermis and western
blotting was performed according to previous reports using specific
antibodies against filaggrin (Abcam,1:1000) and loricrin (Abcam,
1:1000) [58]. Western blotting represents the results from three
separate experiments performed in triplicate.
Statistics
Statistical significance of differences between groups was
analyzed using GraphPad Prism software using student’s unpaired
t-test. All statistical analyses were performed in a double-blinded
manner.
Supporting Information
Figure S1 Characterization of epidermal proliferation
and differentiation in Ctip2
ep2/2 mice. (A) Measurement of
epidermal thickness of WT and Ctip2
ep2/2 mice skin. (B)
Measurement of trans-epidermal water loss (TEWL) from dorsal
skin of wildtype, lesional Ctip2
ep2/2 mice and non-lesional
Ctip2
ep2/2 mice at 4 month. (C) Epidermal percent Ki67 positive
cells in dorsal skin sections of WT and mutant mice. Statistical
analyses were performed by student’s unpaired t-test using
GraphPad Prism software; * P,0.05, ** P,0.005, ***
P,0.0001. Immunohistochemical staining of dorsal skin biopsies
from WT and Ctip2
ep2/2 mice was performed with antibodies
directed against (D) K14 and (E) K10 (all in red). All sections were
counterstained with DAPI (blue). Scale bar (in D and E): 100 mm.
Epidermis (E) and dermis (D) are indicated. (F) Quantitative RT-
PCR (RT-qPCR) analyses of filaggrin in the dorsal skin of 1-week
and 2-week- old wild type (WT) and Ctip2
ep2/2 mice using
specific primers as indicated in Table S1. ** P,0.005. All values
represent relative transcript level after normalization with HPRT
transcripts. (G) Immunoblotting analysis of filaggrin (FLG) and
loricrin (LOR) in the skin of 2-week and 4-month-old wild type
(WT) and Ctip2
ep2/2 mice. b-actin is used as an internal control.
Statistical analyses were performed by student’s unpaired t-test
using GraphPad Prism software; ** P,0.01, *** P,0.001.
(TIF)
Figure S2 Characterization of inflammatory cell infil-
trates in dorsal skin of WT and Ctip2
ep2/2 adult mice.
(A) Toluidine blue stained dorsal paraffin skin sections of WT and
Ctip2
ep2/2 mice. Mast cells stain intensive blue color. Scale bar:
100 mm. (B) Immunohistochemical staining of dorsal skin biopsies
with antibody against CD45 (green). Scale bar: 100 mm. (C)
Percent CD45 positive cells in the dermis of WT and mutant skin.
Statistical analyses were performed by student’s unpaired t-test
using GraphPad Prism software; * P,0.05. Scale bar: 100 mm. (D)
Immunohistochemical staining of CD11c (red) in dorsal skin of
WT and Ctip2
ep2/2 mice. Scale bar: 50 mm. All sections (in B &
D) were counterstained with DAPI (blue).
(TIF)
Figure S3 Relative expression levels of cytokines and
chemokines in WT and Ctip2
ep2/2 skin. The expression
level of (A) IL10, (B) IL1a,( C) IL2, (D) IL12a, (E) IL12b, (F)
IL17a, (G) IL18, (H) IL23, (I) CCL20, (J) CCL22, (K) CXCL10,
(L) CCL3, (M) CXCL2, (N) IFNc and (O) TNFa was studied with
RT-qPCR in 1-month and 4-month-old wildtype and Ctip2
ep2/2
dorsal skin. Values represent relative transcript level after
normalization with HPRT transcripts. Statistical analyses were
performed by student’s unpaired t-test using GraphPad Prism
software; * P,0.05, ** P,0.01, *** P,0.001.
(TIF)
Figure S4 Characterization of TSLP and tight junction
proteins in dorsal skin of 1-month and 4-month-old WT
and in Ctip2
ep2/2 adult mice. Immunohistochemical staining
of dorsal skin biopsies from WT and Ctip2
ep2/2 mice were
performed with specific antibodies against (A) TSLP; (B) b-catenin,
(C) E-cadherin; (D) Claudin-1 and (E) Claudin-4 (all in red). All
sections were counterstained with DAPI (blue). Scale bar: 100 mm.
(TIF)
Figure S5 Relative expression levels of RXRa and genes
involved in Notch signaling pathway. The expression level
of (A) Notch1, (B) Notch2, (C) Rbp-j and (D) RXRa was studied
with RT-qPCR in 1-month and 4-month-old wildtype and
Ctip2
ep2/2 dorsal skin. Values represent relative transcript level
after normalization with GAPDH transcripts. Statistical analyses
were performed by student’s unpaired t-test using GraphPad
Prism software. (E) Immunohistochemical staining of dorsal skin
biopsies with antibody against Notch1 (red) and (F) RXRa (red).
Scale bar: 100 mm. All sections (in E & F) were counterstained
with DAPI (blue).
(TIF)
Figure S6 Immunological abnormalities of spleen and
lymph node in Ctip2
ep2/2 adult mice. (A, D) Hemotoxylin
& Eosin stained 5 mm thick paraffin sections from spleen of WT
and Ctip2
ep2/2 mice at 4 m. (B, C, E, F) C.E.M staining for
eosinophils (pink) and mast cells (blue) in 4 month-old mice spleen
sections. (G, J) Hemotoxylin & Eosin stained 5 mm thick paraffin
sections of WT and Ctip2
ep2/2 mice lymph node at 4 m. (H, I,
K, L) C.E.M staining for eosinophils (pink) and mast cells (blue) in
4 month-old mice lymph node. Black arrows point to eosinophils.
Scale bar: 50 mm.
(TIF)
Figure S7 Expression of Ctip2 in RXRa
ep2/2 mouse
model. (A) Immunohistochemical staining of dorsal skin biopsies
with antibody against Ctip2 (red). Sections were counterstained
with DAPI (blue). NE, normal epidermis; HPE, hyperfroliferative
epidermis. Scale bar: 100 mm. (B) Bar graph indicates the
percentage of Ctip2 positive cells in the dorsal skin of normal
epidermis (NE) from the wildtype (WT) and the hyperproliferative
epidermis (HPE) form RXRa
ep2/2 mice. Statistical analyses were
performed by student’s unpaired t-test using GraphPad Prism
software; ** P,0.01. All experiments were performed in
triplicates.
(TIF)
Table S1 List of primers used for RT-qPCR.
(DOCX)
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